Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.61 USD | +0.71% | +0.97% | +45.89% |
02/05 | Immunome, Inc. Appoints Kinney Horn as Chief Business Officer | CI |
30/04 | JPMorgan Starts Immunome With Overweight Rating, $24 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.89% | 936M | |
+5.66% | 111B | |
+11.23% | 105B | |
-1.98% | 21.93B | |
-12.15% | 22.34B | |
-5.61% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Wedbush Starts Immunome With Outperform Rating, $12 Price Target; Has Positive View for Early-Stage Pipeline of Targeted Cancer Therapies